Pharming Group (OTCMKTS:PHGUF – Get Free Report)’s stock price dropped 8.5% during mid-day trading on Wednesday . The stock traded as low as $0.75 and last traded at $0.75. Approximately 850 shares changed hands during mid-day trading, a decline of 78% from the average daily volume of 3,802 shares. The stock had previously closed at $0.82.
Pharming Group Price Performance
The company has a 50-day simple moving average of $0.82 and a 200-day simple moving average of $0.97. The stock has a market cap of $492.57 million, a PE ratio of -75.50 and a beta of 1.18. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.43 and a quick ratio of 1.16.
About Pharming Group
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks.
See Also
- Five stocks we like better than Pharming Group
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Does GTA VI Make Take-Two Interactive Stock an Irresistible Buy?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Why HPE’s Dip Is a Prime Opportunity for Blue-Chip AI Investors
- Airline Stocks – Top Airline Stocks to Buy Now
- Why Analysts See Big Upside for Occidental Petroleum Despite Lows
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
